HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Split Decision In UFC Athlete's Complaint About Steroid-Containing Supplements

This article was originally published in The Rose Sheet

Executive Summary

Some clams in Ultimate Fighting Championship competitor Lyman Good's complaint against Vitamin Shoppe, Gaspari Nutrition, Hi-Tech Pharmaceuticals and Millennium Sport Technologies will stand. Good's counsel, however, made "threadbare" arguments to sustain other charges he alleged, a judge says in New York federal court.

You may also be interested in...

Health, Beauty And Wellness News: GNC, Momentous, Nutrition 21, Gaspari

GNC online sourcing deal; Gaspari CEO has full control of brand; medical cannabis research partnership in Canada; Momentous occasion of plant protein launch; Innotech Nutrition in US with Colflex preventative spray; AMP Energy wants entrepreneurs; and Nutrition 21's Nitrosigine in C4 Ultimate Shred.

UFC Fighter Hits Genkor Tribulus Supplement With SARMs Complaint

Former UFC heavyweight champ Joshua Barnett's lawsuit filed in California state court two weeks after his suspension from UFC bouts was lifted alleges that BioKor’s Genkor Tributestin 750 supplement he used contained an undeclared ingredient, ostarine, a selective androgen receptor modulator that is a "dangerous chemical that is not approved for human consumption under any circumstances."

One-Two Punch On Supplements From Former FDA Investigator, Harvard Researchers

Jeff Novitzky, VP of athlete health and performance at Ultimate Fighting Championship, discusses violative supplements at a Dietary Supplement Caucus briefing for lawmakers and congressional staff. Harvard researchers roundly criticize the products' potential health benefits.


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts